EIQ.AX is trading 35.5% up at A$1.68 following the announcement of a strategic investment and U.S. distribution partnership with industry leader Pro Medicus.

  • The agreement includes up to A$20 million in secured convertible notes and debt funding, providing the capital certainty required to accelerate international growth.
  • Pro Medicus will act as a U.S. reseller for the EchoSolv platform, significantly fast-tracking Echo IQ’s market penetration and commercialisation efforts.
  • Investors are reacting positively to the endorsement of a major industry player and the potential for rapid scaling within the American healthcare sector.